Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04665284
Status:
COMPLETED
Last Update Posted:
2020-12-11
First Post:
2020-11-27
Brief Title:
Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
Sponsor:
Getz Pharma
Organization:
Getz Pharma
Organization Data
Organization:
Getz Pharma
Class:
INDUSTRY
Study ID:
GTZ-DM-001-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Getz Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None